Israel Charo

Active 1976–2024

111
Papers
35,530
Citations
98
h-index
111
i10-index

Citations

Citations per year for Israel Charo1977: 5 citations1978: 5 citations1979: 6 citations1980: 8 citations1981: 14 citations1982: 10 citations1983: 8 citations1984: 8 citations1985: 17 citations1986: 11 citations1987: 44 citations1988: 24 citations1989: 54 citations1990: 30 citations1991: 38 citations1992: 64 citations1993: 61 citations1994: 92 citations1995: 90 citations1996: 132 citations1997: 242 citations1998: 213 citations1999: 307 citations2000: 267 citations2001: 359 citations2002: 326 citations2003: 379 citations2004: 376 citations2005: 402 citations2006: 370 citations2007: 477 citations2008: 467 citations2009: 444 citations2010: 432 citations2011: 402 citations2012: 406 citations2013: 503 citations2014: 416 citations2015: 471 citations2016: 441 citations2017: 413 citations2018: 386 citations2019: 799 citations2020: 920 citations2021: 864 citations2022: 635 citations2023: 463 citations2024: 670 citations2025: 311 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,350 citing papers, 34.9% of this breakdownChina: 1,308 citing papers, 8.5% of this breakdownGermany: 1,143 citing papers, 7.4% of this breakdownUnited Kingdom: 998 citing papers, 6.5% of this breakdownJapan: 668 citing papers, 4.3% of this breakdownFrance: 640 citing papers, 4.2% of this breakdownCanada: 516 citing papers, 3.4% of this breakdownItaly: 475 citing papers, 3.1% of this breakdownAustralia: 397 citing papers, 2.6% of this breakdownNetherlands: 396 citing papers, 2.6% of this breakdownSwitzerland: 347 citing papers, 2.3% of this breakdownSpain: 264 citing papers, 1.7% of this breakdown
0%34.9%Other 18.5%

Fields

  • Medicine50.7%
  • Immunology and Microbiology24.2%
  • Biochemistry, Genetics and Molecular Biology11.6%
  • Neuroscience10.9%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Nursing0.4%
  • Other1.7%

Topics

  • Chemokine receptors and signaling5.5%
  • Immune cells in cancer5.2%
  • Neuroinflammation and Neurodegeneration Mechanisms4.8%
  • Immune Cell Function and Interaction3.6%
  • Immunotherapy and Immune Responses3.5%
  • T-cell and B-cell Immunology3%
  • Other74.4%

Coauthors

All papers

Open in search
  1. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 332

  2. The Many Roles of Chemokines and Chemokine Receptors in Inflammation

    Authors: , - New England Journal of Medicine 2006 cited by 2,516

  3. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites

    Authors: , , , , , , , - Journal of Clinical Investigation 2007 cited by 1,125

  4. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 546

  5. CCR2 modulates inflammatory and metabolic effects of high-fat feeding

    Authors: , , , , , , , , - Journal of Clinical Investigation 2005 cited by 1,465

  6. Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine

    Authors: , , , , , , , , , , , , , - Immunity 2011 cited by 518

  7. Differential roles of microglia and monocytes in the inflamed central nervous system

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 830

  8. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2015 cited by 454

  9. Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice

    Authors: , , , , , , , - PLoS ONE 2010 cited by 615

  10. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

    Authors: , , , , , , - Journal of Clinical Investigation 1997 cited by 1,101

  11. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

    Authors: , , , - Nature 1998 cited by 1,976

  12. Resolving postoperative neuroinflammation and cognitive decline

    Authors: , , , , , , , , , - Annals of Neurology 2011 cited by 579

  13. Chromatin remodelling drives immune cell–fibroblast communication in heart failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2024 cited by 102

  14. CCR2+ monocytes infiltrate atrophic lesions in age‐related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice

    Authors: , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2013 cited by 317

  15. Langerhans cells renew in the skin throughout life under steady-state conditions

    Authors: , , , , , , , , - Nature Immunology 2002 cited by 937

  16. International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

    Authors: , , , , , , , , - Pharmacological Reviews 2000 cited by 1,806

  17. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2015 cited by 272

  18. CCR2 deficiency alters activation of microglia subsets in traumatic brain injury

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 78

  19. Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study

    Authors: , , , , , , , , , , , , , , , , , , - PLoS ONE 2016 cited by 150

  20. Anti-inflammatory therapeutics for the treatment of atherosclerosis

    Authors: , - Nature Reviews Drug Discovery 2011 cited by 307

  21. Macrophages recruited via CCR2 produce insulin‐like growth factor‐1 to repair acute skeletal muscle injury

    Authors: , , , , , - The FASEB Journal 2010 cited by 251

  22. The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood

    Authors: , , , , , - The Journal of Immunology 2011 cited by 342

  23. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 717

  24. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2009 cited by 399